Effects of Drugs on Cerebral Blood Flow in Patients With Mood Disorders
Healthy, Mood Disorders
About this trial
This is an observational trial for Healthy focused on measuring Bupropion, Carbamazepine, Cerebral Blood Flow, Gabapentin, Lamotrigine, Mood Disorders, Nimodipine, Oxygen-15, Positron Emission Tomography, Venlafaxine
Eligibility Criteria
Healthy volunteers and patients who satisfy DSM-III-R criteria for mood disorders between ages of 18 and 75 will be invited to participate provided that the following criteria are fulfilled: No history of medical illness (including seizures, endocrine, hepatic, renal, cardiac, allergic, infectious, autoimmune, or neurological disorders) that would contraindicate participation. No evidence of co-existing major illness after undergoing complete psychiatric (including SADS-LA interview), medical, neurological, and laboratory examinations (including EEG, EKG, renal and liver function tests, serum electrolytes, urinalysis, HIV, hepatitis B, syphilis). Negative pregnancy test for women of child bearing potential. Women must not be breast feeding. Negative HIV test, as we are studying primary mood and anxiety disorders and not disorders secondary to HIV infection. Negative urine comprehensive drug screen and have not had alcohol or substance abuse problems in last 12 months.
Sites / Locations
- National Institute of Mental Health (NIMH)